MedTrace Logo

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

NCT02144831 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-05-27

No results posted yet for this study

Summary

The primary goal of the research is to determine if 10 days of dual anti-platelet treatment is as effective as 30 days of similar treatment in the prevention of stroke, myocardial ischemia (MI) and death in patients with TIAs and minor stroke.

Conditions

  • Transient Ischemic Attacks
  • Minor Stroke

Interventions

DRUG

anti-thrombotic treatment using Aspirin (ASA 75-325mg) and Clopidogrel (75mg)

comparisson of what is the efficacy and safety of 10 days to 30 day treatment of aspirin (ASA)+Clopidogrel

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Ashfaq Shuaib, MD FRCPC · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-06-30
Completion
2018-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02144831 on ClinicalTrials.gov